Medtech companies Eagle Genomics, Jupiter Diagnostics and The Electrospinning Company raised over £1m, £1.6m and £650k respectively in funding rounds facilitated by Angels in MedCity. The investment will help Eagle Genomics to develop technology that will reduce research costs and time, and help companies get their products to market faster. Jupiter Diagnostics develops a device to perform quick and affordable blood tests. This new round of funding will enable the company to set up an assay production lab and deliver their first sales in Europe in mid-2017. Electrospinning which developed technology to produce electrospun fibres for regenerative medicine and research, will use the investment to upscale production to expand their markets.
All three companies pitched at an Angels in MedCity pitching event in 2016 which included pitch training and business support. 13 companies have so far received funding through the Angels in MedCity initiative raising a total of £12.6m.
Our next pitching event will be on the 26th April where 6 companies will be selected out of a pool of over 30 healthcare and life sciences businesses. Please find all the details here: AiMC Company Presentation Event 26 April 2017
Find the full press releases for the succesful investments here:
- Angels in MedCity supports Eagle Genomics to raise £1m investment
- Jupiter Diagnostics raises £1.6m investment, supported by Angels in MedCity
- The Electrospinning Company raises £650k with participation from Angels in MedCity investors